HEADER TRANSFERASE 20-SEP-16 5P9H TITLE BTK1 COCRYSTALLIZED WITH RN983 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 6 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HI5 KEYWDS PROTEIN KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.S.GARDBERG REVDAT 4 22-MAY-24 5P9H 1 REMARK REVDAT 3 17-NOV-21 5P9H 1 REMARK REVDAT 2 21-FEB-18 5P9H 1 REMARK REVDAT 1 24-MAY-17 5P9H 0 JRNL AUTH A.T.BENDER,A.GARDBERG,A.PEREIRA,T.JOHNSON,Y.WU, JRNL AUTH 2 R.GRENNINGLOH,J.HEAD,F.MORANDI,P.HASELMAYER,L.LIU-BUJALSKI JRNL TITL ABILITY OF BRUTON'S TYROSINE KINASE INHIBITORS TO SEQUESTER JRNL TITL 2 Y551 AND PREVENT PHOSPHORYLATION DETERMINES POTENCY FOR JRNL TITL 3 INHIBITION OF FC RECEPTOR BUT NOT B-CELL RECEPTOR SIGNALING. JRNL REF MOL. PHARMACOL. V. 91 208 2017 JRNL REFN ESSN 1521-0111 JRNL PMID 28062735 JRNL DOI 10.1124/MOL.116.107037 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.36 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 85.2 REMARK 3 NUMBER OF REFLECTIONS : 15683 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.269 REMARK 3 R VALUE (WORKING SET) : 0.267 REMARK 3 FREE R VALUE : 0.313 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 782 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.08 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.21 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1275 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.4497 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1213 REMARK 3 BIN R VALUE (WORKING SET) : 0.4485 REMARK 3 BIN FREE R VALUE : 0.4731 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.86 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 62 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1965 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 24 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.56 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.21120 REMARK 3 B22 (A**2) : 8.75040 REMARK 3 B33 (A**2) : -14.96160 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 1.000 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.286 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.230 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.285 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.231 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.869 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.845 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 18.5190 -18.6762 -11.8277 REMARK 3 T TENSOR REMARK 3 T11: 0.3908 T22: 0.4150 REMARK 3 T33: -0.2831 T12: 0.0014 REMARK 3 T13: 0.0017 T23: 0.0170 REMARK 3 L TENSOR REMARK 3 L11: 1.0550 L22: 1.8685 REMARK 3 L33: 7.1381 L12: -0.2686 REMARK 3 L13: 0.3325 L23: -0.1725 REMARK 3 S TENSOR REMARK 3 S11: -0.0257 S12: 0.0780 S13: 0.0988 REMARK 3 S21: 0.1113 S22: -0.0305 S23: -0.0196 REMARK 3 S31: -0.4575 S32: -0.1280 S33: 0.0562 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5P9H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1001400386. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17653 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 200 DATA REDUNDANCY : 6.010 REMARK 200 R MERGE (I) : 0.23300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.5900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.6 REMARK 200 DATA REDUNDANCY IN SHELL : 5.29 REMARK 200 R MERGE FOR SHELL (I) : 5.21800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.380 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, SODIUM ACTATE, REMARK 280 BISTRISPROPANE, PH 7, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 31.38050 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 50.70200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.38050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 50.70200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 381 REMARK 465 LYS A 382 REMARK 465 ASN A 383 REMARK 465 ALA A 384 REMARK 465 PRO A 385 REMARK 465 SER A 386 REMARK 465 THR A 387 REMARK 465 ALA A 388 REMARK 465 GLY A 389 REMARK 465 LEU A 390 REMARK 465 GLY A 391 REMARK 465 TYR A 392 REMARK 465 GLY A 393 REMARK 465 SER A 394 REMARK 465 SER A 659 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TRP A 395 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 395 CZ3 CH2 REMARK 470 LYS A 400 CG CD CE NZ REMARK 470 PHE A 404 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 406 CG CD CE NZ REMARK 470 GLU A 407 CG CD OE1 OE2 REMARK 470 LYS A 420 CG CD CE NZ REMARK 470 ARG A 422 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 430 CG CD CE NZ REMARK 470 GLU A 434 CG CD OE1 OE2 REMARK 470 GLU A 439 CG CD OE1 OE2 REMARK 470 ASP A 440 CG OD1 OD2 REMARK 470 GLU A 445 CG CD OE1 OE2 REMARK 470 LYS A 447 CG CD CE NZ REMARK 470 VAL A 448 CG1 CG2 REMARK 470 ASN A 451 CG OD1 ND2 REMARK 470 LEU A 452 CG CD1 CD2 REMARK 470 GLU A 455 CG CD OE1 OE2 REMARK 470 LEU A 460 CG CD1 CD2 REMARK 470 THR A 465 OG1 CG2 REMARK 470 LYS A 466 CG CD CE NZ REMARK 470 ARG A 468 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 470 CG1 CG2 CD1 REMARK 470 ILE A 473 CG1 CG2 CD1 REMARK 470 GLN A 496 CG CD OE1 NE2 REMARK 470 LEU A 499 CG CD1 CD2 REMARK 470 GLU A 500 CG CD OE1 OE2 REMARK 470 LYS A 503 CG CD CE NZ REMARK 470 LYS A 515 CG CD CE NZ REMARK 470 ASP A 549 CG OD1 OD2 REMARK 470 VAL A 555 CG1 CG2 REMARK 470 LYS A 558 CG CD CE NZ REMARK 470 GLU A 599 CG CD OE1 OE2 REMARK 470 ARG A 600 CG CD NE CZ NH1 NH2 REMARK 470 THR A 602 OG1 CG2 REMARK 470 SER A 604 OG REMARK 470 GLU A 605 CG CD OE1 OE2 REMARK 470 GLU A 608 CG CD OE1 OE2 REMARK 470 HIS A 609 CG ND1 CD2 CE1 NE2 REMARK 470 ILE A 610 CG1 CG2 CD1 REMARK 470 GLN A 612 CG CD OE1 NE2 REMARK 470 LEU A 614 CG CD1 CD2 REMARK 470 ARG A 615 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 618 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 624 CG CD OE1 OE2 REMARK 470 LYS A 625 CG CD CE NZ REMARK 470 VAL A 626 CG1 CG2 REMARK 470 GLU A 636 CG CD OE1 OE2 REMARK 470 LYS A 637 CG CD CE NZ REMARK 470 ASP A 639 CG OD1 OD2 REMARK 470 LYS A 645 CG CD CE NZ REMARK 470 ASP A 656 CG OD1 OD2 REMARK 470 GLU A 657 CG CD OE1 OE2 REMARK 470 GLU A 658 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 413 31.63 -99.30 REMARK 500 ARG A 422 17.79 59.51 REMARK 500 GLN A 424 -41.29 -142.42 REMARK 500 LYS A 466 49.49 -97.19 REMARK 500 ARG A 520 -9.65 78.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7G7 A 701 DBREF 5P9H A 382 659 UNP Q06187 BTK_HUMAN 416 693 SEQADV 5P9H GLY A 381 UNP Q06187 EXPRESSION TAG SEQRES 1 A 279 GLY LYS ASN ALA PRO SER THR ALA GLY LEU GLY TYR GLY SEQRES 2 A 279 SER TRP GLU ILE ASP PRO LYS ASP LEU THR PHE LEU LYS SEQRES 3 A 279 GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR GLY SEQRES 4 A 279 LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET ILE SEQRES 5 A 279 LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU GLU SEQRES 6 A 279 ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU VAL SEQRES 7 A 279 GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE PHE SEQRES 8 A 279 ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU LEU ASN SEQRES 9 A 279 TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN GLN SEQRES 10 A 279 LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET GLU SEQRES 11 A 279 TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU ALA SEQRES 12 A 279 ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL LYS SEQRES 13 A 279 VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP ASP SEQRES 14 A 279 GLU TYR THR SER SER VAL GLY SER LYS PHE PRO VAL ARG SEQRES 15 A 279 TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE SER SEQRES 16 A 279 SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET TRP SEQRES 17 A 279 GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG PHE SEQRES 18 A 279 THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY LEU SEQRES 19 A 279 ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL TYR SEQRES 20 A 279 THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP GLU SEQRES 21 A 279 ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU ASP SEQRES 22 A 279 VAL MET ASP GLU GLU SER HET 7G7 A 701 46 HETNAM 7G7 6-~{TERT}-BUTYL-8-FLUORANYL-2-[3-(HYDROXYMETHYL)-4-[1- HETNAM 2 7G7 METHYL-5-[[5-(1-METHYLPIPERIDIN-4-YL)PYRIDIN-2- HETNAM 3 7G7 YL]AMINO]-6-OXIDANYLIDENE-PYRIDAZIN-3-YL]PYRIDIN-2- HETNAM 4 7G7 YL]PHTHALAZIN-1-ONE FORMUL 2 7G7 C34 H37 F N8 O3 FORMUL 3 HOH *24(H2 O) HELIX 1 AA1 ASP A 398 LEU A 402 5 5 HELIX 2 AA2 SER A 438 ASN A 451 1 14 HELIX 3 AA3 LEU A 482 GLU A 488 1 7 HELIX 4 AA4 MET A 489 ARG A 492 5 4 HELIX 5 AA5 GLN A 494 LYS A 515 1 22 HELIX 6 AA6 ALA A 523 ARG A 525 5 3 HELIX 7 AA7 GLY A 541 TYR A 545 5 5 HELIX 8 AA8 ASP A 548 SER A 553 1 6 HELIX 9 AA9 PRO A 560 SER A 564 5 5 HELIX 10 AB1 PRO A 565 SER A 572 1 8 HELIX 11 AB2 SER A 575 SER A 592 1 18 HELIX 12 AB3 THR A 602 GLY A 613 1 12 HELIX 13 AB4 SER A 623 CYS A 633 1 11 HELIX 14 AB5 LYS A 637 ARG A 641 5 5 HELIX 15 AB6 THR A 643 ASP A 656 1 14 SHEET 1 AA1 5 PHE A 404 GLY A 411 0 SHEET 2 AA1 5 GLY A 414 TRP A 421 -1 O TYR A 418 N LYS A 406 SHEET 3 AA1 5 TYR A 425 MET A 431 -1 O MET A 431 N VAL A 415 SHEET 4 AA1 5 PHE A 471 GLU A 475 -1 O THR A 474 N ALA A 428 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 AA2 3 GLY A 480 CYS A 481 0 SHEET 2 AA2 3 CYS A 527 VAL A 529 -1 O VAL A 529 N GLY A 480 SHEET 3 AA2 3 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 CISPEP 1 ARG A 468 PRO A 469 0 6.06 SITE 1 AC1 18 LEU A 408 THR A 410 GLY A 411 PHE A 413 SITE 2 AC1 18 VAL A 416 ALA A 428 THR A 474 GLU A 475 SITE 3 AC1 18 MET A 477 ALA A 478 GLY A 480 ASN A 526 SITE 4 AC1 18 LEU A 528 ASP A 539 LEU A 542 SER A 543 SITE 5 AC1 18 VAL A 546 TYR A 551 CRYST1 62.761 101.404 38.100 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015933 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009862 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026247 0.00000